Menu
Search
|

Menu

Close
X

Apollo Endosurgery Inc APEN.OQ (NASDAQ Stock Exchange Global Market)

3.20 USD
-- (--)
As of Nov 13
chart
Previous Close 3.20
Open --
Volume --
3m Avg Volume 11,633
Today’s High --
Today’s Low --
52 Week High 9.56
52 Week Low 3.16
Shares Outstanding (mil) 17.25
Market Capitalization (mil) 94.37
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.75 Mean rating from 4 analysts

KEY STATS

Revenue (mm, USD)
FY18
32
FY17
64
FY16
65
FY15
68
EPS (USD)
FY18
-1.000
FY17
-2.148
FY16
-108.276
FY15
-608.947
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
33.64
Price to Sales (TTM)
vs sector
1.50
5.95
Price to Book (MRQ)
vs sector
2.08
4.89
Price to Cash Flow (TTM)
vs sector
--
22.90
Total Debt to Equity (MRQ)
vs sector
117.56
17.74
LT Debt to Equity (MRQ)
vs sector
117.56
13.15
Return on Investment (TTM)
vs sector
-120.83
14.22
Return on Equity (TTM)
vs sector
-210.67
15.99

EXECUTIVE LEADERSHIP

Richard Meelia
Chairman of the Board, Since 2012
Salary: --
Bonus: --
Todd Newton
Chief Executive Officer, Director, Since 2014
Salary: $400,000.00
Bonus: --
Stefanie Cavanaugh
Chief Financial Officer, Secretary, Since 2015
Salary: --
Bonus: --
Bret Schwartzhoff
Vice President,North America Sales and Global Marketing, Since 2017
Salary: $267,267.00
Bonus: --
Christopher Gostout
Chief Medical Officer, Since 2017
Salary: $220,000.00
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

1120 South Capital Of Tx Hwy
Building 1 Suite 300
WEST LAKE HILLS   TX   78746-6464

Phone: +1512.2795100

Apollo Endosurgery, Inc., formerly Lpath, Inc., is a medical device company. The Company is focused on less invasive therapies for the treatment of obesity, as well as other gastrointestinal disorders. The Company's device-based therapies are an alternative to invasive surgical procedures. The Company offers products in over 80 countries. The Company's products include ORBERA, LAP-BAND and OverStitch. The Company's product, ORBERA, is a gastric balloon. The ORBERA Intragastric Balloon System is a weight loss aid for adults suffering from obesity. The LAP-BAND System is a minimally invasive procedure that offers weight loss. The LAP-BAND System is indicated for weight reduction for patients with obesity. The OverStitch Endoscopic Suturing System enables advanced endoscopic surgery by allowing physicians to place full-thickness sutures through a flexible endoscope. OverStitch offers solutions for defects in both the upper and lower gastrointestinal tract.

SPONSORED STORIES